Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease

被引:135
作者
Sly, LM [1 ]
Krzesicki, RF [1 ]
Brashler, JR [1 ]
Buhl, AE [1 ]
McKinley, DD [1 ]
Carter, DB [1 ]
Chin, JE [1 ]
机构
[1] Pharmacia Corp, CNS Genom, Kalamazoo, MI 49007 USA
关键词
neuroinflammation; neurodegeneration; beta-amyloid; chemokine; interleukin; complement;
D O I
10.1016/S0361-9230(01)00730-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
beta-Amyloid (Abeta) plaques have been shown to induce inflammatory changes in Alzheimer's disease brains. Cortical, but not cerebellar tissue from 16-month-old Tg2576 (Tg+) mice showed significant increases in interleukin (IL)-1alpha (2.2-fold), IL-1beta (3.4-fold), tumor necrosis factor-alpha (3.9-fold), and monocyte chemoattractant protein-1 (2.5-fold) mRNA levels compared to controls (Tg-). These changes were not apparent in 6-month-old Tg+ mice except for TNF-alpha. mRNA levels of glial fibrillary acidic protein and complement components, C1qA and C3 were also elevated in aged mice. Lipopolysaccharide (LPS) (25 mug/mouse, i.v.) induced a significantly greater production of IL-1beta protein in the cortices and hippocampi of Tg+ vs. Tg-mice at 1, 2, 4, and 6 h. Experiments in 6-month-old mice showed that not only was there less cytokine produced compared to 16-month-old mice, but the exacerbated cytokine response to LIPS in Tg+ mice was not apparent. Higher levels of Abeta1-40 were measured in the cortices of 6- and 16-month-old Tg+ mice at 4-6 h after LPS, which returned to baseline after 18 h. We demonstrate that Abeta plaques elicit inflammatory responses in Tg2576 mice that are further exacerbated when challenged by an exogenous inflammatory insult, which may serve to amplify degenerative processes. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:581 / 588
页数:8
相关论文
共 57 条
  • [1] Localization and cell association of C1q in Alzheimer's disease brain
    Afagh, A
    Cummings, BJ
    Cribbs, DH
    Cotman, CW
    Tenner, AJ
    [J]. EXPERIMENTAL NEUROLOGY, 1996, 138 (01) : 22 - 32
  • [2] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [3] Evidence for glial-mediated inflammation in aged APPSW transgenic mice
    Benzing, WC
    Wujek, JR
    Ward, EK
    Shaffer, D
    Ashe, KH
    Younkin, SG
    Brunden, KR
    [J]. NEUROBIOLOGY OF AGING, 1999, 20 (06) : 581 - 589
  • [4] Costimulatory effects of interferon-γ and interleukin-1β or tumor necrosis factor α on the synthesis of aβ1-40 and aβ1-42 by human astrocytes
    Blasko, I
    Veerhuis, R
    Stampfer-Kountchev, M
    Saurwein-Teissl, M
    Eikelenboom, P
    Grubeck-Loebenstein, B
    [J]. NEUROBIOLOGY OF DISEASE, 2000, 7 (06) : 682 - 689
  • [5] Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide
    Bradt, BM
    Kolb, WP
    Cooper, NR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (03) : 431 - 438
  • [6] Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
    Chapman, PF
    White, GL
    Jones, MW
    Cooper-Blacketer, D
    Marshall, VJ
    Irizarry, M
    Younkin, L
    Good, MA
    Bliss, TVP
    Hyman, BT
    Younkin, SG
    Hsiao, KK
    [J]. NATURE NEUROSCIENCE, 1999, 2 (03) : 271 - 276
  • [7] Genes, models and Alzheimer's disease
    Chapman, PF
    Falinska, AM
    Knevett, SG
    Ramsay, MF
    [J]. TRENDS IN GENETICS, 2001, 17 (05) : 254 - 261
  • [8] Cotman CW, 1996, NEUROBIOL AGING, V17, P723
  • [9] Alzheimer's disease - Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
    Cummings, JL
    Vinters, HV
    Cole, GM
    Khachaturian, ZS
    [J]. NEUROLOGY, 1998, 51 (01) : S2 - S17
  • [10] Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
    De Strooper, B
    Saftig, P
    Craessaerts, K
    Vanderstichele, H
    Guhde, G
    Annaert, W
    Von Figura, K
    Van Leuven, F
    [J]. NATURE, 1998, 391 (6665) : 387 - 390